Metabolic Syndrome, Insulin Resistance, and Roles of Inflammation – Mechanisms and Therapeutic Targets
Year: 2012
Type: review
Abstract: Obesity and its comorbidities, including type 2 diabetes mellitus and cardiovascular disease, are associated with a state of chronic low-grade inflammation that can be detected both systemically and within specific tissues. Areas of active investigation focus on the molecular bases of metabolic inflammation and potential pathogenic roles in insulin resistance, diabetes, and cardiovascular disease. An increased accumulation of macrophages occurring in obese adipose tissue has emerged as a key process in metabolic inflammation. Recent studies have also begun to unravel the heterogeneity of adipose tissue macrophages, and their physical and functional interactions with adipocytes, endothelial cells, and other immune cells within the adipose tissue microenvironment. Translating the information gathered from experimental models of insulin resistance and diabetes into meaningful therapeutic interventions is a tantalizing goal with long-term global health implications. In this context, ongoing clinical studies are testing the effects of targeting inflammation systemically on metabolic and cardiovascular outcomes.
Institutions: Joslin Diabetes Center, Harvard University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Mechanism-Based Biomarkers for Glucose-Lowering in TINSAL-T2D, G148497706, Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate, IKK MEDIATED INSULIN RESISTANCE AND IN VIVO REVERSAL, Mediators and Modifiers of NF-kappaB in Insulin Resistance, Boston Nutrition Obesity Research Center, Diabetes Research Center
OpenAlex ID: W2117893382
